PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
213 hedge funds and large institutions have $1.18B invested in PDL BioPharma, Inc. in 2015 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 73 increasing their positions, 69 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 69
Holders
213
Holding in Top 10
–
Calls
$3.29M
Puts
$1.51M
Top Buyers
| 1 | +$19.4M | |
| 2 | +$5.45M | |
| 3 | +$4.75M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$4.53M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$2.61M |
Top Sellers
| 1 | -$220M | |
| 2 | -$14.3M | |
| 3 | -$12.8M | |
| 4 |
GAM
Gotham Asset Management
New York
|
-$11M |
| 5 |
LCP
Lombardia Capital Partners
Pasadena,
California
|
-$10.5M |